Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 93, Issue 1
What should we do about vaccination of patients on anti-CD20 antibody therapy?
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Editorial commentary
What should we do about vaccination of patients on anti-CD20 antibody therapy?
Free
Online download statistics by month:
Online download statistics by month: August 2021 to July 2022
Abstract
Full
Pdf
Aug 2021
890
892
150
Sep 2021
179
177
27
Oct 2021
270
262
15
Nov 2021
106
104
10
Dec 2021
611
610
65
Jan 2022
492
490
74
Feb 2022
184
191
37
Mar 2022
120
122
27
Apr 2022
103
104
9
May 2022
132
129
15
Jun 2022
98
97
7
Jul 2022
101
100
6
Total
3286
3278
442
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF